A Multicentre, Open 12-Month Study to Assess the Tolerance of Fluticasone Propionate Administered Via the Pressurised Inhaler at Doses Between 100?g bd (200?g/day) and 500?g bd (1000?g/day) in Adult Patients with Mild to Moderate Asthma, Trial ID FMS30040

A Multicentre, Open 12-Month Study to Assess the Tolerance of Fluticasone Propionate Administered Via the Pressurised Inhaler at Doses Between 100?g bd (200?g/day) and 500?g bd (1000?g/day) in Adult Patients with Mild to Moderate Asthma, Trial ID FMS30040 | GSK